Navigation Links
HealthShares(TM) Announces Quarterly Rebalancing of HealthShares(TM) Indexes
Date:9/17/2007

NEW YORK, Sept. 17 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today has been informed that Standard & Poor's, the official calculating agent for the HealthShares(TM) Indexes, has performed the quarterly rebalancing on the Indexes.

The following securities will be added and deleted in the Indexes effective before the opening of trading on the New York Stock Exchange September 21, 2007. Autoimmune-Inflammation Drop Nektar Therapeutics Nasdaq: NKTR Add Pharmacopeia, Inc. Nasdaq: PCOP Cardiology Drop Atherogenics, Inc. Nasdaq: AGIX Add Hospira, Inc. NYSE: HSP Diagnostics Drop Fresenius Medical Care AG Xetra: FME GY Add Techne Corp Nasdaq: TECH GI/Gender Health Drop Schwarz Pharma AG Xetra: SRZ GY Add Richter Gedeon NYRT Budapest: RICHT HB Metabolic-Endocrine Disorders Drop GTX, Inc. Nasdaq: GTXI

Add Indevus Pharmaceuticals, Inc. Nasdaq: IDEV Neuroscience Drop Schwarz Pharma AG Xetra: SRZ GY Add Forest Laboratories, Inc. NYSE: FRX Emerging Cancer Drop Hana Bioscience, Inc. Nasdaq: HNAB Axcan Pharma, Inc. Nasdaq: AXCA Isis Pharmaceuticals Nasdaq: ISIS

Add GPC Biotech AG-Sponsored ADR Nasdaq: GPCB QLT, Inc.

Nasdaq: QLTI Allos Therapeutics, Inc. Nasdaq: ALTH

Cancer Drop Fresenius Medical Care AG Xetra: FME GY GPC Biotech AG-Sponsored ADR Nasdaq: GPCB QLT, Inc. Nasdaq: QLTI Add Hospira, Inc. NYSE: HSP Seattle Genetics, Inc. Nasdaq: SGEN Isis Pharmaceuticals, Inc. Nasdaq: ISIS European Drugs Drop Novo Nordisk A/S B Shares Copenhagen: NOVOB


'/>"/>

SOURCE HealthShares(TM) Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 2FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 3FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 1CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 2CBI Announces FDA Participation at Upcoming Forum on Clinical Trial Investigator Portals 14631 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 1Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 2Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 3Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 4Novavax and CPL Biologicals Break Ground on New Influenza Vaccine Manufacturing Facility in India 14627 5Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 1Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 2Breast Health is a Year Round Priority 3A New Technology Identifies Risk of Breast Cancer in Younger Women 5779 3